Onderneming Alterity Therapeutics Limited
Aandelen
ATH
AU0000043945
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,005 AUD | +25,00% |
|
+11,11% | -28,57% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 63 | 01-05-17 |
Geoffrey Kempler
FOU | Founder | 69 | 11-11-97 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 01-05-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Geoffrey Kempler
FOU | Founder | 69 | 11-11-97 |
Peter Marks
BRD | Director/Board Member | 68 | 29-07-05 |
Lawrence Gozlan
BRD | Director/Board Member | 45 | 08-08-11 |
Brian Meltzer
BRD | Director/Board Member | 70 | 09-12-99 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 802 360 380 | 2 436 015 074 ( 86,93 %) | 0 | 86,93 % |
Bedrijfsgegevens
Alterity Therapeutics Ltd.
350 Collins Street Level 14
3000, Melbourne
+61 3 9349 4906
http://www.alteritytherapeutics.com![Adres Alterity Therapeutics Limited(ATH)](https://cdn.zonebourse.com/static/address/57291688.png)
Sector
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-28,57% | 14 mln. | |
+19,41% | 45,51 mld. | |
-8,62% | 38,52 mld. | |
+38,31% | 38,13 mld. | |
+26,95% | 30,74 mld. | |
-13,50% | 26,03 mld. | |
+10,74% | 25,92 mld. | |
+44,87% | 14,13 mld. | |
+34,36% | 12,73 mld. | |
-7,14% | 11,29 mld. |